Mednet Logo
HomeQuestion

Would you ever consider focal brachytherapy treatment in a patient who have in-prostate recurrences after RT?

3
5 Answers
Mednet Member
Mednet Member
Radiation Oncology · David Geffen School of Medicine at UCLA

Yes, our preference is focal treatment for unilateral disease on imaging (PSMA, PET, and MRI) and concordant biopsies. Our data suggest that this is just as effective as whole gland treatment for recurrences with possibly less toxicity.

For patients b/l recurrent involvement after prior radiation tr...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Beth Israel Deaconess Medical Center/Harvard Medical School

Yes: Have been doing this since 2002. Over 100 cases.
No grade 3 or higher rectal toxicity. One patient with grade 4 urinary toxicity. It occurred after a false passage during catheterization.

Lessons learned:

Careful patient selection:

More difficult for local failure after brachytherapy than EBRT ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · The Ottawa Hospital

Yes, but I take many factors into account:

  1. Disease - should be unifocal site with concordant MR/PET and biopsies. If diffuse disease or other suspicious areas, would treat whole gland.
  2. Patient - if the patient's disease is eligible for focal, I next consider the patient's baseline GU/GI function. I...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Florida

Yes

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Northeast Georgia Medical Center

Yes. Confirmed with biopsy, PSMA PET, and directed by MRI. I typically place hydrogel immediately after the HDR implant.

Register or Sign In to see full answer